Elixirgen Therapeutics, Inc.
Reimagine the Power of RNA
13 employees · est. 2017 · Baltimore, United States
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases
25 employees · est. 2012 · South San Francisco, United...
Quince Therapeutics is the older company (2017 vs 2012).
Side-by-Side Comparison
| Metric | Elixirgen Therapeutics, Inc. | Quince Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2012 older |
| Headquarters | ||
| Headquarters | Baltimore, United States | South San Francisco, United States |
| Employees | ||
| Employees | 13 | 25 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $25.91M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 5 | 6 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | RNA Therapeutics, MRNA Technology, Cell And Gene Therapies, Rare And Genetic Diseases, Aging-related Disorders, Duchenne Muscular Dystrophy, C-srRNA™ Technology, Telomere Biology Disorders, Stem Cell Biology, Regenerative Medicine, Johns Hopkins Science + Technology Park, Biotechnology Company, Intellectual Property, Drug Development, Clinical-stage | Rare Diseases Treatment, Neurodegenerative Diseases, Drug Delivery Technology, Clinical Trials, FDA Approval Process, Fast Track Designation, Pediatric Medicine, Pharmaceutical Development, Preclinical Studies |
| Website | ||
| Website | elixirgentx.com | quincetx.com |
About Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. is a biotechnology startup that is making significant strides in the field of RNA therapeutics. The company's focus lies in developing innovative therapies, including cell and gene therapies, to address a wide range of diseases such as rare and genetic disorders, as well...
About Quince Therapeutics
Quince Therapeutics is a late-stage biotechnology company aiming to leverage the patient’s own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, utilizes the proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which encapsulates a d...
We will tell you when either one moves
BounceWatch watches Elixirgen Therapeutics, Inc. and Quince Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Elixirgen Therapeutics... and Quince Therapeutics — by email.
Frequently Asked Questions
Compare Elixirgen Therapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Elixirgen Therapeutics, Inc. on 14 Sep 2024, and Quince Therapeutics on 18 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
